CAVINATO, MIRIAM
CAVINATO, MIRIAM
Dipartimento di Bioscienze
STRATEGIES TO TARGET HUMAN D-ASPARTATE OXIDASE AND MODULATE ENDOGENOUS D-ASPARTATE LEVELS IN SCHIZOPHRENIA
2026 M. Cavinato
PROTAC-mediated degradation of peroxisomal d-aspartate oxidase: A novel strategy to modulate d-aspartate homeostasis for schizophrenia treatment
2026 M. Galli, V. Rabattoni, M. Cavinato, F. Vasile, I. Gado, K. Ulfat, H. Shehi, A. Silvani, D. Passarella, A. Citarella, L. Pollegioni, M. Nardini
Design, synthesis and biological evaluation of PROTACs targeting hDASPO
2025 M. Galli, A. Citarella, M. Cavinato, I. Gado, V. Rabattoni, H. Shehi, M. Nardini, A. Silvani, V. Fasano, F. Vasile, L. Pollegioni, D. Passarella
PROTAC technology for the degradation of hDASPO: from design to synthesis to biophysical and cellular evaluation
2025 M. Galli, A. Citarella, M. Cavinato, I. Gado, V. Rabattoni, H. Shehi, M. Nardini, A. Silvani, V. Fasano, F. Vasile, L. Pollegioni, D. Passarella
Structural basis of Nuclear Factor 1-X DNA recognition provides prototypic insight into the NFI family
2025 M. Tiberi, M. Lapi, L.J. Gourlay, A. Chaves-Sanjuan, M. Polentarutti, N. Demitri, M. Cavinato, D.M.V. Bonnet, V. Taglietti, A. Righetti, R. Sala, S. Cauteruccio, A. Kumawat, R. Russo, A.G. Barbiroli, N. Gnesutta, C. Camilloni, M. Bolognesi, G. Messina, M. Nardini
A Green Approach to Nucleophilic Aromatic Substitutions of Nicotinic Esters in Cyrene
2024 A. Citarella, M. Cavinato, A. Amenta, M. Nardini, A. Silvani, D. Passarella, V. Fasano
Nicotinic Acid Derivatives As Novel Noncompetitive α-Amylase and α-Glucosidase Inhibitors for Type 2 Diabetes Treatment
2024 A. Citarella, M. Cavinato, E. Rosini, H. Shehi, F. Ballabio, C. Camilloni, V. Fasano, A. Silvani, D. Passarella, L. Pollegioni, M. Nardini
Application of the PROTAC technology for the modulation of hDASPO activity
2024 M. Galli, A. Citarella, M. Cavinato, I. Gado, V. Rabattoni, H. Shehi, M. Nardini, A. Silvani, V. Fasano, F. Vasile, L. Pollegioni, D. Passarella